BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of a loss of$0.15 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +180.00$1.03 per share when it actually produced earnings of $1.44, delivering a surprise of +39.8 ...